NEPHROGENEX INC COM
NRX
NRX was delisted on the 10th of May, 2016.
1 hedge funds and large institutions have $0 invested in NEPHROGENEX INC COM in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 16 closing their positions.
94% less funds holding
Funds holding: 17 → 1 (-16)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1.15M → $0 (-$1.15M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 16
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCP
Rho Capital Partners
New York
|
-$495K |
| 2 |
VAM
Visium Asset Management
New York
|
-$371K |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$184K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$35K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RCP
1
Rho Capital Partners
New York
| – | -$495K | -1,052,966 | Closed |
|
|
VAM
2
Visium Asset Management
New York
| – | -$371K | -790,000 | Closed |
|
|
BI
3
BVF Inc
San Francisco,
California
| – | -$184K | -392,156 | Closed |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| – | -$35K | -73,514 | Closed |
|
5
Geode Capital Management
Boston,
Massachusetts
| – | -$19 | -40,911 | Closed |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$18K | -38,899 | Closed |
|
7
JP Morgan Chase
New York
| – | -$15K | -31,536 | Closed |
|
|
VKH
8
Virtu KCG Holdings
New York
| – | -$12K | -24,767 | Closed |
|
9
Goldman Sachs
New York
| – | -$9K | -18,736 | Closed |
|
|
BFA
10
BlackRock Fund Advisors
San Francisco,
California
| – | -$7K | -15,848 | Closed |
|
11
UBS Group
Zurich,
Switzerland
| – | -$4K | -8,573 | Closed |
|
12
Bank of America
Charlotte,
North Carolina
| – | -$1K | -2,000 | Closed |
|
|
EWM
13
Edge Wealth Management
New York
| – | -$1K | -500 | Closed |
|
NRX Hedge Fund Activity: Q2 2016 in Review
1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NEPHROGENEX INC COM (NRX) for Q2 2016, worth a combined $0 — down 100% from $1.15M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of NRX and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Rho Capital Partners, exiting entirely with an estimated $495K sold.
- 1 institutional investor held NEPHROGENEX INC COM (NRX) as of Q2 2016, down from 17 in Q1 2016.
- Funds reported $0 of NEPHROGENEX INC COM stock for Q2 2016, down 100% quarter-over-quarter.
- 0 funds opened new NEPHROGENEX INC COM positions in Q2 2016 and 16 closed out, a net change of -16 holders.
- The largest NEPHROGENEX INC COM seller in Q2 2016 was Rho Capital Partners, an estimated $495K sold.
Based on aggregated 13F filings for Q2 2016.